Published in Dokl Biochem Biophys on February 08, 2007
Recent insights into the general stress response regulatory network in Escherichia coli. J Mol Microbiol Biotechnol (2002) 1.83
Reductive dehalogenation of chlorinated dioxins by an anaerobic bacterium. Nature (2003) 1.81
Fatty acid regulation of gene transcription. J Biol Chem (2000) 1.66
Novel lipid components of the Azotobacter vinelandii cyst membrane. Nature (1983) 1.26
[DNA-binding lipids: composition and possible functions]. Biokhimiia (1993) 1.06
Nuclear phospholipase C and signaling. Biochim Biophys Acta (2001) 1.05
DNA-bound lipids of normal and tumor cells: retrospective and outlooks for functional genomics. Bioelectrochemistry (2002) 0.94
[Induction of SOS-response of cells exposed to autoregulatory factors of microorganisms]. Genetika (2003) 0.92
Fatty acids as markers of starfish food sources. Dokl Biol Sci (2003) 0.87
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
On the validity of the Beck Depression Inventory. A review. Psychopathology (1998) 3.16
Country profile: Germany. Lancet (1996) 2.77
A sensitive and specific method for the determination of histomine in human whole blood and plasma. Hoppe Seylers Z Physiol Chem (1972) 2.43
The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report. Am J Public Health Nations Health (1966) 2.42
Optimal methods for guideline implementation: conclusions from Leeds Castle meeting. Med Care (2001) 2.41
Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J Biol Chem (1991) 2.35
Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem (1990) 2.35
Expectations and quality of life of cancer patients undergoing radiotherapy. J R Soc Med (2000) 1.61
Comparison of the 14-C-putrescine assay with the NADH test for the determination of diamine oxidase: description of a standard procedure with a high precision and an improved accuracy. Agents Actions (1973) 1.57
Erythromelalgia in a patient with systemic lupus erythematosus treated with clonazepam. J Rheumatol (1990) 1.55
How asymptomatic is asymptomatic primary hyperparathyroidism? Exp Clin Endocrinol Diabetes (2000) 1.49
Isoprenylation of a protein kinase. Requirement of farnesylation/alpha-carboxyl methylation for full enzymatic activity of rhodopsin kinase. J Biol Chem (1992) 1.45
Muscular involvement in systemic rheumatoid vasculitis. Br J Rheumatol (1992) 1.44
Erythermalgia, erythromelalgia, or both? Conditions neglected by rheumatologists. J Rheumatol (1993) 1.42
The human VK locus. Characterization of a duplicated region encoding 28 different immunoglobulin genes. J Mol Biol (1988) 1.37
Histamine and peptic ulcer: influence of sample-taking on the precision and accuracy of fluorometric histamine assay in biopsies of human gastric mucosa. Agents Actions (1980) 1.34
Histamine and peptic ulcer: a prospective study of mucosal histamine concentration in duodenal ulcer patients and in control subjects suffering from various gastrointestinal diseases. Klin Wochenschr (1976) 1.33
Cloning, expression and functional analyses of the catabolite control protein CcpA from Bacillus megaterium. Mol Microbiol (1995) 1.31
Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion. Eur J Cancer (2001) 1.31
Effect of the Anti-Coronary Club program on coronary heart disease. Risk-factor status. JAMA (1966) 1.31
A strong magnetic field around the supermassive black hole at the centre of the Galaxy. Nature (2013) 1.27
Factors associated with fetal losses in severe systemic lupus erythematosus. Lupus (1996) 1.27
Histamine content and mast cells in human gastric and duodenal mucosa. Agents Actions (1978) 1.24
Studies on the mode of action of histamine H1- and H2-receptor antagonists on gastric histamine methyltransferase. Agents Actions (1973) 1.23
Symptom reporting in cancer patients: the role of negative affect and experienced social stigma. Cancer (1996) 1.23
The alpha 1C-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity. Mol Pharmacol (1991) 1.22
Sequences of ccpA and two downstream Bacillus megaterium genes with homology to the motAB operon from Bacillus subtilis. Gene (1994) 1.20
Histamine release in dogs by Cremophor E1 and its derivatives: oxethylated oleic acid is the most effective constituent. Agents Actions (1977) 1.20
Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proc Natl Acad Sci U S A (1990) 1.11
Effect of selective gastric vagotomy on histamine concentration in gastric mucosa of patients with duodenal ulcer. Br J Surg (1978) 1.11
Histamine release in man. Agents Actions (1975) 1.11
Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol (2000) 1.11
Florometric histamine determination in canine plasma under normal conditions, following application of exogenous histamine, and during histamine release by haemaccel. Hoppe Seylers Z Physiol Chem (1974) 1.08
Flares from a candidate Galactic magnetar suggest a missing link to dim isolated neutron stars. Nature (2008) 1.08
Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab (2011) 1.07
[Histamine release during induction of combination anesthesia using nalbuphine or fentanyl. Modulation of the reaction by premedication with promethazine/pethidine]. Anaesthesist (1992) 1.07
Histamine release in clinical conditions. Mt Sinai J Med (1978) 1.07
Histamine and peptic ulcer disease: histamine methyltransferase activity in gastric mucosa of control subjects and duodenal ulcer patients before and after surgical treatment. Agents Actions (1977) 1.07
Diamine oxidase activity and histamine release in dogs following acute mesenteric artery occlusion. Agents Actions (1977) 1.06
Human intestinal diamine oxidase: substrate specificity and comparative inhibitor study. Agents Actions (1980) 1.06
Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis. Infect Immun (2001) 1.05
Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta (1983) 1.04
On the mechanism and stereochemistry of the malate-lactate fermentation of Leuconostoc mesenteroides. Hoppe Seylers Z Physiol Chem (1976) 1.03
Histamine release after intravenous application of short-acting hypnotics. A comparison of etomidate, Althesin (CT1341) and propanidid. Br J Anaesth (1973) 1.02
Histamine release induced by opioid analgesics: a comparative study using porcine mast cells. Agents Actions (1991) 1.02
Histamine release in human subjects by modified gelatin (Haemaccel) and dextran: an explanation for anaphylactoid reactions observed under clinical conditions? Br J Anaesth (1976) 1.00
Contribution of glucose kinase to glucose repression of xylose utilization in Bacillus megaterium. J Bacteriol (1997) 1.00
An improved method for the determination of histamine release in man: its application in studies with propanidid and thiopentone. Eur J Pharmacol (1972) 0.99
H1 + H2-receptor antagonists for premedication in anaesthesia and surgery: a critical view based on randomized clinical trials with Haemaccel and various antiallergic drugs. Agents Actions (1980) 0.99
The influence of carcinoma growth on diamine oxidase activity in human gastrointestinal tract. Agents Actions (1980) 0.98
Release of histamine by H2-receptor antagonists. Lancet (1982) 0.98
Autoimmune thyroid disease in primary Sjögren's syndrome. Am J Med (1995) 0.97
[Outcome of minimally invasive surgery. Qualitative analysis and evaluation of the clinical relevance of study variables by the patient and physician]. Chirurg (2001) 0.97
Nasogastric tube versus gastrostomy tube for gastric decompression in abdominal surgery: a prospective, randomized trial comparing patients' tube-related inconvenience. Langenbecks Arch Surg (2001) 0.97
A phylogenetic study on the occurrence and distribution of histamine in the gastro-intestinal tract and other tissues of man and various animals. Comp Gen Pharmacol (1973) 0.97
[Salivary gland secretion following administration of pilocarpine, histamine and kinins]. Arch Int Pharmacodyn Ther (1966) 0.96
[Not Available]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2002) 0.96
Histamine release in man by propanidid and thiopentone: pharmacological effects and clinical consequences. Br J Anaesth (1972) 0.96
Intestinal diamine oxidase and histamine release in rabbit mesenteric ischemia. Gastroenterology (1981) 0.95
Elements of the rabbit uteroglobin promoter mediating its transcription in epithelial cells from the endometrium and lung. Gene Expr (1992) 0.95
Food-induced histaminosis as an epidemiological problem: plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DAO). Agents Actions (1988) 0.95
Quality of life profile: from measurement to clinical application. Breast (2002) 0.94
Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer (2012) 0.94
Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial. J Rheumatol (1984) 0.93
[Histamine in salivary glands, tonsils and thymus and adaptive histamine formation in the submaxillary gland]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.93
Evaluation of histamine elimination curves in plasma and whole blood of several circulatory regions: a method for studying kinetics of histamine release in the whole animal. Agents Actions (1974) 0.93
Primary breast cancer therapy in six regions of Germany. Eur J Cancer (2002) 0.93
[Assessment of quality of life in health services research - conceptual, methodological and structural prerequisites]. Gesundheitswesen (2009) 0.93
Inhibition of intestinal diamine oxidase by detergents: a problem for drug formulations with water insoluble agents applied by the intravenous route? Agents Actions (1987) 0.92
Effect of gastrin receptor blockade on endocrine cells in rats during achlorhydria. Gastroenterology (1992) 0.92
Histamine and stress ulcer: new components in organizing a sequential trial on cimetidine prophylaxis in seriously ill patients and definition of a special group at risk (severe polytrauma). Klin Wochenschr (1980) 0.91
Comparison of alterations in the histamine-diamine oxidase system during acute intestinal ischaemia in pigs, dogs and rabbits; evidence for a uniform pathophysiological mechanism? Agents Actions (1979) 0.91
Inhibition and activation of histamine methyltransferase by methylated histamines. Hoppe Seylers Z Physiol Chem (1973) 0.91
The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme. Cancer Lett (2000) 0.91
Plasma histamine levels in patients in the course of several standard operations: influence of anaesthesia, surgical trauma and blood transfusion. Klin Wochenschr (1982) 0.91
[Histamine release in submaxillary gland and pancreas by parasympathomimetic drugs, peptide hormones, histamine and mepyramine]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.90
Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT. Br J Cancer (2008) 0.90
Elevated plasma histamine concentrations in surgery: causes and clinical significance. Klin Wochenschr (1974) 0.90
Histamine and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress ulcer formation by (+)-catechin, an inhibitor of specific histidine decarboxylase in vitro. Agents Actions (1977) 0.90
Solvent for etomidate may cause pain and adverse effects. Br J Anaesth (1999) 0.90
[On a new method for the determination of diamine oxidase activity]. Hoppe Seylers Z Physiol Chem (1967) 0.90
Symptom reporting in cancer patients II: relations to social desirability, negative affect, and self-reported health behaviors. Cancer (1999) 0.88
Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis. Langenbecks Arch Surg (2001) 0.88
Does laparoscopy increase bacteremia and endotoxemia in a peritonitis model? Surg Endosc (1997) 0.87
Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis (1998) 0.87
Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject. Klin Wochenschr (1982) 0.87
Polymorphonuclear leukocyte heterogeneity in neonates and adults. Blood (1986) 0.87
Pulse steroid therapy, rheumatoid arthritis and the Journal of Rheumatology. J Rheumatol (1988) 0.86
Quality of life research in patients with rectal cancer: traditional approaches versus a problem-solving oriented perspective. Langenbecks Arch Surg (1998) 0.86
Histamine and histamine methyltransferase in the gastric mucosa of man, pig, dog and cow. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.86
Metabolism and function of gastric histamine in health and disease. J Clin Gastroenterol (1983) 0.86
Histamine in the pigs: determination, distribution, release and pharmacological actions. Eur J Pharmacol (1971) 0.86
Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes. Clin Pharmacol Ther (1995) 0.86
The wafer test: a semi-quantitative test to screen for xerostomia. Rheumatology (Oxford) (2002) 0.86
Survival of the quality of life concept. Br J Surg (2003) 0.86
[Measuring quality of life in after-care of tumor surgery. Methods, problems and applications]. Chirurg (1994) 0.85
Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial. Int Urogynecol J (2012) 0.85